PMV Pharma

PMV Pharma is a biopharmaceutical company dedicated to developing first-in-class p53 regulators for the treatment of cancer. The company's unique approach focuses on structurally correcting mutated p53 proteins, restoring their tumor-suppressing function. PMV Pharma has a pipeline of promising clinical-stage candidates and leverages its deep expertise in p53 biology to advance its mission of conquering cancer.